Ann: THC Global cannabis product available via prescription, page-48

The SP was 68c at Apr 2018. LOL.

On a serious note, I agree with your observation that other pot stocks, particularly CAN, do not seem to have done much in recent year. THC has accomplished a lot. My thoughts are that because our strategy is vertically integrated and strictly focused on fundamentals, it is hard to produce some headline-grabbing news, like an off-take agreement worth x million dollars.

Even after launching the actual products, we cannot say some ground-breaking numbers, because it really depends on the uptake of the patients and no middleman to guarantee revenue(again, like an off-take agreement). So no SP pumping as a result.

The only thing is to wait for the Quarterly in .... July.